clinical trial · NCT00397358
Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients
Vantive Health LLC·phase4·withdrawn
Peritoneal DialysisHypertriglyceridemiaExtraneal (7.5% icodextrin) Peritoneal Dialysis Solution
brief summary
This is a Phase IV study evaluating triglyceride levels in peritoneal dialysis patients.
started
Nov 1, 2006
primary completion
Jun 1, 2007
completion
Jun 1, 2007
last updated
Mar 3, 2025
detailed description
This prospective, open label, multi-center study evaluates the use of 7.5% icodextrin used in the long-dwell exchange in peritoneal dialysis patients with elevated triglyceride levels. Fasting triglyceride levels will be measured during the study.
official title
Open-label Study to Evaluate the Effects of Once Daily Extraneal (7.5% Icodextrin) Peritoneal Dialysis Solution on Triglyceride Levels in Peritoneal Dialysis Patients
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol